Cite
HARVARD Citation
Blevins, T. et al. (2017). Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus. Postgraduate medicine. 129 (1), pp. 159-168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Blevins, T. et al. (2017). Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus. Postgraduate medicine. 129 (1), pp. 159-168. [Online].